IMMURON LTD revenue for the last year amounted to 3.05 M EUR, the most of which — 3.05 M EUR — came from its highest performing source at the moment, Hyper-immune Products, the year earlier bringing 1.10 M EUR. The greatest contribution to the revenue figure was made by Australia — last year it brought IMMURON LTD 2.33 M EUR, and the year before that — 708.71 k EUR.